Truxton Corporation (TRUX)
OTCMKTS · Delayed Price · Currency is USD
81.00
0.00 (0.00%)
Jul 31, 2025, 8:00 PM EDT
Verve Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 26.06 | 33.01 | 7.68 | 6.5 | 99.49 | 90.93 | Upgrade |
Investment Securities | 493 | 144.55 | 137.89 | 139.23 | 183.7 | 118.96 | Upgrade |
Trading Asset Securities | - | 5.88 | 6.02 | 7.44 | 1.1 | 2.74 | Upgrade |
Mortgage-Backed Securities | - | 114.02 | 122.53 | 121.86 | 121.58 | 90.29 | Upgrade |
Total Investments | 493 | 264.45 | 266.43 | 268.53 | 306.38 | 211.99 | Upgrade |
Gross Loans | 692.12 | 670.88 | 658.7 | 619.83 | 495.48 | 420.44 | Upgrade |
Allowance for Loan Losses | -6.69 | -6.43 | -6.3 | -5.76 | -4.78 | -4.49 | Upgrade |
Other Adjustments to Gross Loans | - | -0.9 | -0.86 | -0.88 | -0.68 | -0.81 | Upgrade |
Net Loans | 685.43 | 663.55 | 651.54 | 613.19 | 490.02 | 415.14 | Upgrade |
Property, Plant & Equipment | 3.09 | 7.58 | 0.41 | 0.44 | 1 | 1.64 | Upgrade |
Accrued Interest Receivable | 5.57 | 4.57 | 4.39 | 3.51 | 2.35 | 2.65 | Upgrade |
Restricted Cash | - | 0.97 | 1.55 | - | - | 3.17 | Upgrade |
Long-Term Deferred Tax Assets | 5.39 | 5.26 | 6.01 | 7.16 | 0.06 | - | Upgrade |
Other Long-Term Assets | 38.18 | 23.05 | 16.29 | 15.56 | 15.52 | 13.66 | Upgrade |
Total Assets | 1,257 | 1,004 | 955.27 | 917.28 | 917.26 | 741.62 | Upgrade |
Interest Bearing Deposits | 919.24 | 570.71 | 546.29 | 559.16 | 576.12 | 427.85 | Upgrade |
Institutional Deposits | - | 169.7 | 111.78 | 94.72 | 15.66 | 25.92 | Upgrade |
Non-Interest Bearing Deposits | 129.23 | 126.02 | 123.92 | 153.87 | 215.7 | 170.25 | Upgrade |
Total Deposits | 1,048 | 866.42 | 781.98 | 807.75 | 807.48 | 624.03 | Upgrade |
Short-Term Borrowings | - | 2.14 | 2.44 | 7.98 | 0.78 | 3.9 | Upgrade |
Current Portion of Long-Term Debt | - | 5.25 | - | - | - | - | Upgrade |
Current Portion of Leases | - | 4.6 | 0.22 | - | - | - | Upgrade |
Long-Term Debt | 18.96 | 14.43 | 68.13 | 14.73 | 14.63 | 14.53 | Upgrade |
Federal Home Loan Bank Debt, Long-Term | 72 | 3 | 4.5 | 4.5 | 4.5 | 17.67 | Upgrade |
Long-Term Leases | - | - | - | 0.24 | 0.68 | 1.13 | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | - | - | - | 0.48 | Upgrade |
Other Long-Term Liabilities | 12.67 | 9.23 | 10.32 | 8.71 | 5.14 | 3.22 | Upgrade |
Total Liabilities | 1,154 | 905.08 | 867.59 | 843.9 | 833.21 | 664.96 | Upgrade |
Common Stock | 0.28 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | Upgrade |
Additional Paid-In Capital | 28.86 | 28.95 | 31.46 | 31.11 | 31.79 | 31.37 | Upgrade |
Retained Earnings | 84.34 | 79.73 | 69.22 | 59.49 | 49.63 | 41.43 | Upgrade |
Comprehensive Income & Other | -10.63 | -10.25 | -13.28 | -17.51 | 2.35 | 3.57 | Upgrade |
Shareholders' Equity | 102.85 | 98.71 | 87.68 | 73.38 | 84.05 | 76.66 | Upgrade |
Total Liabilities & Equity | 1,257 | 1,004 | 955.27 | 917.28 | 917.26 | 741.62 | Upgrade |
Total Debt | 90.96 | 29.42 | 75.29 | 27.44 | 20.59 | 37.23 | Upgrade |
Net Cash (Debt) | -64.66 | 9.72 | -61.11 | -9.68 | 82.78 | 59.37 | Upgrade |
Net Cash Growth | - | - | - | - | 39.43% | 161.39% | Upgrade |
Net Cash Per Share | -23.02 | 3.44 | -21.56 | -3.42 | 29.31 | 21.28 | Upgrade |
Filing Date Shares Outstanding | 2.88 | 2.87 | 2.89 | 2.89 | 2.88 | 2.86 | Upgrade |
Total Common Shares Outstanding | 2.88 | 2.87 | 2.89 | 2.89 | 2.88 | 2.86 | Upgrade |
Book Value Per Share | 35.75 | 34.42 | 30.31 | 25.41 | 29.19 | 26.77 | Upgrade |
Tangible Book Value | 102.85 | 98.71 | 87.68 | 73.38 | 84.05 | 76.66 | Upgrade |
Tangible Book Value Per Share | 35.75 | 34.42 | 30.31 | 25.41 | 29.19 | 26.77 | Upgrade |
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.